|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Katz MH, Pisters PW, Evans DB, Sun CC, Lee
JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, et al:
Borderline resectable pancreatic cancer: The importance of this
emerging stage of disease. J Am Coll Surg. 206:833–846. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Geer RJ and Brennan MF: Prognostic
indicators for survival after resection of pancreatic
adenocarcinoma. Am J Surg. 165:68–72. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagaraj S, Gupta K, Pisarev V, Kinarsky L,
Sherman S, Kang L, Herber DL, Schneck J and Gabrilovich DI: Altered
recognition of antigen is a mechanism of CD8+ T cell tolerance in
cancer. Nat Med. 13:828–835. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zou W: Immunosuppressive networks in the
tumour environment and their therapeutic relevance. Nat Rev Cancer.
5:263–274. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Greenwald RJ, Freeman GJ and Sharpe AH:
The B7 family revisited. Annu Rev Immunol. 23:515–548. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Subudhi SK, Alegre ML and Fu YX: The
balance of immune responses: Costimulation verse coinhibition. J
Mol Med Berl. 83:193–202. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Driessens G, Kline J and Gajewski TF:
Costimulatory and coinhibitory receptors in anti-tumor immunity.
Immunol Rev. 229:126–144. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chapoval AI, Ni J, Lau JS, Wilcox RA,
Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K and Chen L:
B7-H3: A costimulatory molecule for T cell activation and IFN-gamma
production. Nat Immunol. 2:269–274. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Prasad DV, Nguyen T, Li Z, Yang Y, Duong
J, Wang Y and Dong C: Murine B7-H3 is a negative regulator of T
cells. J Immunol. 173:2500–2506. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suh WK, Gajewska BU, Okada H, Gronski MA,
Bertram EM, Dawicki W, Duncan GS, Bukczynski J, Plyte S, Elia A, et
al: The B7 family member B7-H3 preferentially down-regulates T
helper type 1-mediated immune responses. Nat Immunol. 4:899–906.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu CP, Jiang JT, Tan M, Zhu YB, Ji M, Xu
KF, Zhao JM, Zhang GB and Zhang XG: Relationship between
co-stimulatory molecule B7-H3 expression and gastric carcinoma
histology and prognosis. World J Gastroenterol. 12:457–459.
2006.PubMed/NCBI
|
|
13
|
Sun Y, Wang Y, Zhao J, Gu M, Giscombe R,
Lefvert AK and Wang X: B7-H3 and B7-H4 expression in non-small-cell
lung cancer. Lung Cancer. 53:143–151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Crispen PL, Sheinin Y, Roth TJ, Lohse CM,
Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich
BC, et al: Tumor cell and tumor vasculature expression of B7-H3
predict survival in clear cell renal cell carcinoma. Clin Cancer
Res. 14:5150–5157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zang X, Thompson RH, Al-Ahmadie HA, Serio
AM, Reuter VE, Eastham JA, Scardino PT, Sharma P and Allison JP:
B7-H3 and B7x are highly expressed in human prostate cancer and
associated with disease spread and poor outcome. Proc Natl Acad Sci
USA. 104:19458–19463. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamato I, Sho M, Nomi T, Akahori T,
Shimada K, Hotta K, Kanehiro H, Konishi N, Yagita H and Nakajima Y:
Clinical importance of B7-H3 expression in human pancreatic cancer.
Br J Cancer. 101:1709–1716. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prasad DV, Richards S, Mai XM and Dong C:
B7S1, a novel B7 family member that negatively regulates T cell
activation. Immunity. 18:863–873. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tringler B, Zhuo S, Pilkington G, Torkko
KC, Singh M, Lucia MS, Heinz DE, Papkoff J and Shroyer KR: B7-H4 is
highly expressed in ductal and lobular breast cancer. Clin Cancer
Res. 11:1842–1848. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tringler B, Liu W, Corral L, Torkko KC,
Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J and Shroyer
KR: B7-H4 overexpression in ovarian tumors. Gynecol Oncol.
100:44–52. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Krambeck AE, Thompson RH, Dong H, Lohse
CM, Park ES, Kuntz SM, Leibovich BC, Blute ML, Cheville JC and Kwon
ED: B7-H4 expression in renal cell carcinoma and tumor vasculature:
Associations with cancer progression and survival. Proc Natl Acad
Sci USA. 103:10391–10396. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Awadallah NS, Shroyer KR, Langer DA,
Torkko KC, Chen YK, Bentz JS, Papkoff J, Liu W, Nash SR and Shah
RJ: Detection of B7-H4 and p53 in pancreatic cancer: Potential role
as a cytological diagnostic adjunct. Pancreas. 36:200–206. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Greene FL, Page DL, Fleming ID, Fritz AG,
Balch CM, Haller DG and Morrow M: Exocrine pancreas. AJCC Cancer
Staging Manual (6th). (New York, NY). Springer. 157–164. 2002.
|
|
23
|
Klöppel G, Hruban RH, Longneck DS, Adler
G, Kern SE and Partanen TJ: Tumours of the exocrine pancreas. In:
World Health Organization Classification of Tumours. Pathology and
Genetics of Tumours of the Digestive System. Hamilton SR and
Aaltonen LA: 2:(Lyon). IARC Press. 219–252. 2000.
|
|
24
|
Zhou YH, Chen YJ, Ma ZY, Xu L, Wang Q,
Zhang GB, Xie F, Ge Y, Wang XF and Zhang XG: 4IgB7-H3 is the major
isoform expressed on immunocytes as well as malignant cells. Tissue
Antigens. 70:96–104. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen LJ, Sun J, Wu HY, Zhou SM, Tan Y, Tan
M, Shan BE, Lu BF and Zhang XG: B7-H4 expression associates with
cancer progression and predicts patient's survival in human
esophageal squamous cell carcinoma. Cancer Immunol Immunother.
60:1047–1055. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fauci JM, Straughn JM Jr, Ferrone S and
Buchsbaum DJ: A review of B7-H3 and B7-H4 immune molecules and
their role in ovarian cancer. Gynecol Oncol. 127:420–425. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yi KH and Chen L: Fine tuning the immune
response through B7-H3 and B7-H4. Immunol Rev. 229:145–151. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen XL, Yuan SX, Chen C, Mao YX, Xu G and
Wang XY: Expression of B7-H1 protein in human pancreatic carcinoma
tissues and its clinical significance. Ai Zheng. 28:1328–1332.
2009.(In Chinese). PubMed/NCBI
|
|
29
|
Nomi T, Sho M, Akahori T, Hamada K, Kubo
A, Kanehiro H, Nakamura S, Enomoto K, Yagita H, Azuma M and
Nakajima Y: Clinical significance and therapeutic potential of the
programmed death-1 ligand/programmed death-1 pathway in human
pancreatic cancer. Clin Cancer Res. 13:2151–2157. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qian Y, Hong B, Shen L, Wu Z, Yao H and
Zhang L: B7-H4 enhances oncogenicity and inhibits apoptosis in
pancreatic cancer cells. Cell Tissue Res. 353:139–151. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Roth TJ, Sheinin Y, Lohse CM, Kuntz SM,
Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML,
et al: B7-H3 ligand expression by prostate cancer: A novel marker
of prognosis and potential target for therapy. Cancer Res.
67:7893–7900. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kuang DM, Zhao Q, Peng C, Xu J, Zhang JP,
Wu C and Zheng L: Activated monocytes in peritumoral stroma of
hepatocellular carcinoma foster immune privilege and disease
progression through PD-L1. J Exp Med. 206:1327–1337. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mugler KC, Singh M, Tringler B, Torkko KC,
Liu W, Papkoff J and Shroyer KR: B7-H4 expression in a range of
breast pathology: Correlation with tumor T cell infiltration. Appl
Immunohistochem Mol Morphol. 15:363–370. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Simon I, Katsaros D, de la Longrais
Rigault I, Massobrio M, Scorilas A, Kim NW, Sarno MJ, Wolfert RL
and Diamandis EP: B7-H4 is over-expressed in early-stage ovarian
cancer and is independent of CA125 expression. Gynecol Oncol.
106:334–341. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Choi IH, Zhu G, Sica GL, Strome SE,
Cheville JC, Lau JS, Zhu Y, Flies DB, Tamada K and Chen L: Genomic
organization and expression analysis of B7-H4, an immune inhibitory
molecule of the B7 family. J Immunol. 171:4650–4654. 2003.
View Article : Google Scholar : PubMed/NCBI
|
